相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson et al.
NATURE (2020)
The many lives of KATs - detectors, integrators and modulators of the cellular environment
Bilal N. Sheikh et al.
NATURE REVIEWS GENETICS (2019)
LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia
Yusuke Tarumoto et al.
MOLECULAR CELL (2018)
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
Konstantinos Tzelepis et al.
NATURE COMMUNICATIONS (2018)
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
Jon Kerry et al.
CELL REPORTS (2017)
MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches
Amanda C. Winters et al.
FRONTIERS IN PEDIATRICS (2017)
Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis
Daria G. Valerio et al.
CANCER RESEARCH (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
BRPF3-HBO1 regulates replication origin activation and histone H3K14 acetylation
Yunpeng Feng et al.
EMBO JOURNAL (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML
Tim Sauer et al.
EXPERIMENTAL HEMATOLOGY (2015)
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors
Mo Chen et al.
GENES & DEVELOPMENT (2015)
Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia
Ross M. W. Thorne et al.
HAEMATOLOGICA (2015)
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Junwei Shi et al.
NATURE BIOTECHNOLOGY (2015)
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Vincent-Philippe Lavallee et al.
NATURE GENETICS (2015)
Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia
Ross M. W. Thorne et al.
HAEMATOLOGICA (2015)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
Mark Wunderlich et al.
BLOOD (2013)
Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity
Marie-Eve Lalonde et al.
GENES & DEVELOPMENT (2013)
Acute myeloid leukaemia in adults
Felicetto Ferrara et al.
LANCET (2013)
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Jolanta Grembecka et al.
NATURE CHEMICAL BIOLOGY (2012)
The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis
Yuta Mishima et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
HBO1 Is Required for H3K14 Acetylation and Normal Transcriptional Activity during Embryonic Development
Andrew J. Kueh et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis
Andrew G. Muntean et al.
CANCER CELL (2010)
MYST family histone acetyltransferases take center stage in stem cells and development
Anne K. Voss et al.
BIOESSAYS (2009)
Moz and Retinoic Acid Coordinately Regulate H3K9 Acetylation, Hox Gene Expression, and Segment Identity
Anne K. Voss et al.
DEVELOPMENTAL CELL (2009)
Modifications of RNA polymerase II are pivotal in regulating gene expression states
Emily Brookes et al.
EMBO REPORTS (2009)
An auxin-based degron system for the rapid depletion of proteins in nonplant cells
Kohei Nishimura et al.
NATURE METHODS (2009)
Menin critically links MLL proteins with LEDGE on cancer-associated target genes
Akihiko Yokoyama et al.
CANCER CELL (2008)
Role of Jade-1 in the Histone Acetyltransferase (HAT) HBO1 Complex
Rebecca L. Foy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia
S. Esteyries et al.
LEUKEMIA (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
The MYST family of histone acetyltransferases and their intimate links to cancer
N. Avvakumov et al.
ONCOGENE (2007)
ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation
Y Doyon et al.
MOLECULAR CELL (2006)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
I Kitabayashi et al.
LEUKEMIA (2001)
分享论文
